News | Angiography | January 31, 2024

SCAI Publishes Expert Consensus Statement on Management of Calcified Coronary Lesions Requiring Intervention

Outlines methods for interventional cardiologists to identify types of calcified coronary lesions and presents an algorithm to guide the use of calcium modification strategies 

Outlines methods for interventional cardiologists to identify types of calcified coronary lesions and presents an algorithm to guide the use of calcium modification strategies

Getty Images


January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during procedures such as percutaneous coronary intervention (PCI) and adverse events in the short and long term. Along with these challenges, treatment options are expanding, increasingly including calcium modification prior to stent implantation. A newly published SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions outlines methods for interventional cardiologists to identify various types of calcified coronary lesions and presents an algorithm to help them guide the use of these various calcium modification strategies. 

“This expert consensus statement incorporates detailed tips for the use of each treatment modality and the latest in emerging trials and therapies to help interventional cardiologists rise to these challenges,” said SCAI President George D. Dangas, MD, PhD, MSCAI. 

In addition to outlining methods for identifying various types of calcified lesions and reviewing the different calcium modifying tools, “the document provides images using two different types of intravascular imaging technology and a consensus of practical tips when using the different treatment strategies, including in the use of different types of calcified lesion subsets,” said Binita Shah, MD, MS, FSCAI, Chair of the document’s writing committee, associate professor of medicine at NYU School of Medicine and associate director of interventional cardiology for VA NY Harbor Healthcare System. “We bring the data and our experience all together with an algorithm designed to identify and address the various calcified CAD phenotypes. Our group is proud of this document and the uniqueness of it.” 

Among the consensus document’s many takeaways, highlights include: 

  • Calcified coronary lesions are becoming commonplace in the cardiac catheterization lab, and their treatment is associated with increased short- and long-term risks compared to noncalcified lesions. 
  • The use of intravascular imaging and the proper use of calcium modification devices can help decrease these risks. 
  • The authors propose an algorithm for how to identify and treat these lesions with the various currently available calcium modification devices, along with tips and tricks for using these devices. 

“This consensus statement is meant to increase awareness about the prevalence of calcified coronary lesions, the ramifications of testing these lesions when indicated, the various treatment options available including tips for using them, and offer an algorithm for choosing between these treatment options,” said Robert F. Riley, MD, MS, FSCAI, director of the complex coronary therapeutics program at Overlake Medical Center & Clinics

For the interventional cardiologist community, “our hope is that this document aids in improving outcomes for some of our most challenging patients,” said Mitul Patel, MD, FSCAI, interventional cardiologist, VA San Diego Health System

For more information: www.scai.org 


Related Content

News | SCAI

May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...

Home May 07, 2024
Home
News | SCAI

May 7, 2024 — Women and black patients were less frequently treated with minimally invasive therapy compared to men or ...

Home May 07, 2024
Home
News | SCAI

May 1, 2024 — The annual Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific ...

Home May 01, 2024
Home
News | SCAI

June 1, 2023 — New insights from the TWILIGHT trial showed that ticagrelor monotherapy after three months of ticagrelor ...

Home June 01, 2023
Home
News | SCAI

May 24, 2023 — The largest interventional study focused on pulmonary embolisms highlighted importance of rapid removal ...

Home May 24, 2023
Home
Feature | SCAI | Christine Book

May 23, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) welcomed its 46th President and 2023 ...

Home May 23, 2023
Home
News | SCAI

May 19, 2023 — Findings from a study examining the relationship between marijuana use and peripheral artery disease (PAD ...

Home May 19, 2023
Home
News | SCAI

February 7, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) announced the second application ...

Home February 07, 2023
Home
News | SCAI

January 18, 2023 — the Society for Cardiovascular Angiography & Interventions (SCAI) announced four recipients of their ...

Home January 18, 2023
Home
News | SCAI

December 8, 2022 — The Society for Cardiovascular Angiography & Interventions (SCAI), a leading nonprofit medical ...

Home December 08, 2022
Home
Subscribe Now